Related Experiment Video
Updated: Jan 26, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Maternal smoking and neurodevelopmental outcomes in infants <29 weeks gestation: a multicenter cohort study
Krystyna Ediger1, Shabih U Hasan1,2, Anne Synnes3
1Department of Pediatrics, University of Calgary, Calgary, AB, Canada.
Insights
Maternal smoking during pregnancy is linked to poorer neurodevelopmental outcomes in preterm infants. Exposed infants showed higher risks of death or neurodevelopmental impairment and lower motor scores at 18-21 months corrected age.
Area of Science:
- Neonatal research
- Developmental pediatrics
- Public health
Background:
- Maternal smoking during pregnancy is a known risk factor for adverse birth outcomes.
- Preterm infants face heightened risks for neurodevelopmental challenges.
- Understanding the long-term neurodevelopmental impact of prenatal smoke exposure is crucial.
Purpose of the Study:
- To compare neurodevelopmental outcomes in preterm infants exposed to maternal smoking versus those not exposed.
- To assess the association between prenatal smoke exposure and a composite outcome of death or neurodevelopmental impairment (NDI).
- To evaluate specific neurodevelopmental domains, including motor function, in relation to maternal smoking.
Main Methods:
- A cohort of preterm infants (<29 weeks gestation) evaluated at 18-21 months corrected age (CA) was studied.
- Infants were categorized based on maternal smoking status during pregnancy.
- Neurodevelopmental outcomes, including a composite of death or NDI and Bayley-III motor scores, were assessed.
Main Results:
- Of 2061 infants, 280 (13.6%) had prenatal smoke exposure.
- Exposed infants had higher odds of the composite outcome (death or NDI) (aOR 1.40).
- Higher odds of NDI alone (aOR 1.43) and lower Bayley-III motor scores (aOR 1.91) were observed in exposed infants.
Conclusions:
- Prenatal exposure to maternal smoking is associated with adverse neurodevelopmental outcomes in preterm infants.
- This includes an increased risk of death or neurodevelopmental impairment and poorer motor function.
- Findings highlight the importance of smoking cessation interventions for pregnant women.
Objective:
To compare neurodevelopmental outcomes of preterm infants at 18-21 months corrected age (CA) whose mothers smoked during pregnancy to those whose mothers did not smoke.
Study Design:
Preterm infants born at <29 weeks of gestation and evaluated at 18-21 months CA were included. Primary outcome was a composite outcome of death or neurodevelopmental impairment (NDI).
Results:
Of a total of 2760 infants, 699 met exclusion criteria. Of the remaining 2061 infants, 280 (13.6%) were exposed to maternal smoking and 1781 (86.4%) were not. The odds of the composite outcome of death or NDI (aOR 1.40; 95% CI: 1.03-1.91), NDI alone (aOR 1.43; 95% CI: 1.01-2.03), and Bayley-III motor score <85 (aOR 1.91; 95% CI: 1.31-2.81) were higher in exposed infants.
Conclusions:
Exposure to maternal smoking was associated with adverse composite outcome of death or NDI, NDI alone and lower motor scores at 18-21 months CA.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Drug Dosing: Infants and Children
Case Studies

